VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHeinrich-Heine University, Duesseldorf

About this trial

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

Eligibility criteria

Qualifiers

High-grade aortic valve stenosis

Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI)

Existing heart center decision

Age ≥ 18 years

Disqualifiers

Surgery planned under general anesthesia

Language barrier, defined as insufficient language proficiency at the discretion of the investigator to understand the purpose of the trial and follow the VR application.

Severe hearing impairment, preventing the patient from understanding the sound of the VR goggles, tested with the VR goggles fitted without using the VRAP-Heart software

Severe visual impairment that prevents viewing of the VR modules if it is not possible to use existing visual corrections (contact lenses, glasses) together with the VR glasses in the event of defective vision, tested with the VR goggles fitted without using the VRAP-Heart software

Trial design

Treatments tested in this trial

  • Virtual Reality assisted information

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators